Infectious Disease and Microbiology – Leclercia adecarboxylata

Overview

Leclercia adecarboxylata is a Gram-negative bacillus belonging to the Enterobacterales. It is widely distributed in the environment but is a rare cause of human infection.

When clinically significant infection occurs, it is often opportunistic and may present as bacteremia, respiratory tract infection, or part of a polymicrobial soft-tissue or abscess infection.

Classification

Genus: Leclercia

Species: Leclercia adecarboxylata

Group: Enterobacterales

Historically, this organism has sometimes been confused with Escherichia coli because of similarities in biochemical characteristics.

Microbiologic Characteristics

L. adecarboxylata is:

• Gram-negative bacillus

• Facultatively anaerobic, although older sources may describe it as aerobic

• Motile

• A member of Enterobacterales

• Generally considered an opportunistic organism

Accurate identification may require modern biochemical or molecular laboratory methods because it can resemble other enteric Gram-negative bacilli.

Incubation Period

The incubation period is:

Unknown

There is no characteristic incubation period because infections can arise from several different routes and clinical circumstances.

Epidemiology

L. adecarboxylata has a:

Worldwide distribution

but is a:

Rare cause of human infection

The organism has been recovered from environmental sources such as:

• Water

• Soil

• Other environmental material

Opportunistic Infection

Clinically important disease has particularly been described in patients with:

• Immunosuppression

• Serious underlying disease

• Invasive medical devices

• Disrupted skin or mucosal barriers

• Traumatic wounds

However, infection can occasionally occur in immunocompetent individuals as well.

Bacteremia

L. adecarboxylata can cause:

Bacteremia

Bloodstream infection may occur as an isolated infection or secondary to another infectious focus.

Possible manifestations include:

• Fever

• Chills

• Systemic inflammatory response

• Sepsis in severe cases

Catheter-Associated Infection

Because opportunistic Gram-negative organisms can colonize or infect intravascular devices, L. adecarboxylata has also been reported in association with:

Catheter-related bloodstream infection

When a device-associated infection is suspected, appropriate source control may be necessary in addition to antimicrobial therapy.

Respiratory Tract Infection

The source identifies:

Respiratory tract infections

as another clinical manifestation.

These infections are uncommon and are more clinically significant when the organism is isolated from an appropriate lower respiratory specimen in a patient with compatible signs of infection.

Polymicrobial Infection

An important characteristic is that L. adecarboxylata may occur as part of:

Polymicrobial infections

rather than as the only pathogen.

Examples include:

• Abscesses

• Wound infections

• Soft-tissue infections

Therefore, treatment may need to cover other organisms isolated from the same infectious focus.

Wound and Soft-Tissue Infection

Environmental exposure combined with disruption of the skin barrier can permit L. adecarboxylata to enter tissues.

A useful clinical pattern is:

Traumatic wound

• ●

Environmental contamination

• ●

Gram-negative bacillus isolated from wound/abscess

→ Consider Leclercia adecarboxylata among the uncommon environmental pathogens.

Diagnosis

The principal diagnostic method is:

Culture

Depending on the clinical syndrome, specimens may include:

• Blood

• Respiratory secretions

• Wound cultures

• Abscess material

• Tissue specimens

Laboratory Identification

Because L. adecarboxylata can resemble other Enterobacterales, particularly E. coli, accurate species-level identification may occasionally be challenging.

Modern methods such as:

MALDI-TOF mass spectrometry

can facilitate reliable identification.

Treatment

The source lists:

Fluoroquinolones

as a treatment option.

Additional Treatment

The source also lists:

• Trimethoprim-sulfamethoxazole (TMP-SMX)

• Beta-lactam/beta-lactamase inhibitor combinations

These may be effective depending on the susceptibility of the isolate.

Antimicrobial Susceptibility

Many reported L. adecarboxylata isolates have been susceptible to multiple antimicrobial classes.

However, resistance can occur, including isolates with clinically important beta-lactam resistance mechanisms.

Therefore, treatment of invasive disease should be guided by:

Culture and antimicrobial susceptibility testing

rather than assuming universal susceptibility.

Treatment Principle

For significant L. adecarboxylata infection:

Confirm clinical significance

↓

Determine whether infection is monomicrobial or polymicrobial

↓

Perform susceptibility testing

↓

Choose an active antimicrobial

↓

Provide source control when an abscess or infected device is present

This is particularly important because many reported infections involve wounds, abscesses, or medical devices.

Colonization vs. True Infection

Because L. adecarboxylata is an uncommon organism and can occur in polymicrobial specimens, its clinical significance should be interpreted carefully.

Evidence supporting true infection includes:

• Isolation from a normally sterile site

• Repeated positive cultures

• Compatible clinical manifestations

• Isolation from a deep wound or abscess

• Clinical response to targeted treatment

Leclercia vs. Escherichia coli

Leclercia adecarboxylata

→ Rare opportunistic pathogen

→ Environmental distribution

→ Bacteremia, respiratory and wound infections

→ Frequently encountered in polymicrobial infection

→ Can resemble E. coli in the laboratory

Escherichia coli

→ Common human intestinal flora

→ Very common human pathogen

→ UTI, bacteremia, intra-abdominal infection, and diarrheal disease

→ Much more frequently encountered clinically

High-Yield Clinical Pattern

Rare Gram-negative bacillus

• ●

Immunocompromised patient or disrupted tissue barrier

• ●

Bacteremia, respiratory infection, wound infection, or abscess

• ●

Possible polymicrobial infection

→ Think Leclercia adecarboxylata

Exam Essentials

Organism: Leclercia adecarboxylata

Morphology: Gram-negative bacillus

Group: Enterobacterales

Distribution: Worldwide

Frequency: Rare human pathogen

Environmental association: Soil and water

Incubation: Unknown

Major infection: Bacteremia

Other infections: Respiratory tract, wound, and soft-tissue infections

Important pattern: May occur in polymicrobial abscesses

Important hosts: Often opportunistic, especially with impaired host defenses or disrupted barriers

Diagnosis: Culture

Laboratory issue: May be confused with E. coli

Source treatment: Fluoroquinolone

Additional source treatments: TMP-SMX and beta-lactam/beta-lactamase inhibitor combinations

Management principle: Susceptibility-guided therapy and appropriate source control

Key clinical pearl: Leclercia adecarboxylata is a rare environmental Gram-negative bacillus that should be considered a potential opportunistic pathogen when recovered from blood, deep wounds, or abscesses. It is particularly notable for appearing in polymicrobial infections and for its laboratory resemblance to Escherichia coli.

Infectious Disease and Microbiology – Lassa Virus

Overview

Lassa virus is an enveloped RNA virus in the family Arenaviridae that causes Lassa fever, a viral hemorrhagic fever endemic in West Africa.

Humans usually acquire infection through exposure to urine or feces from the multimammate rat, Mastomys natalensis, although person-to-person transmission can also occur through contact with infected body fluids.

Classification

Virus: Lassa virus

Family: Arenaviridae

Genus: Mammarenavirus

Disease: Lassa fever

The source groups it under the arenaviruses.

Microbiologic Characteristics

Lassa virus is:

• Enveloped

• An RNA virus

• Characterized by two single-stranded RNA genome segments

• Helical in nucleocapsid organization

• An arenavirus

The genome segments are conventionally called:

L segment

and

S segment

Genome Organization

The viral genome is:

Segmented single-stranded RNA

with two major segments.

Arenaviruses have an ambisense coding strategy, meaning that portions of the genome encode proteins in opposite orientations.

Epidemiology

Lassa fever occurs primarily in:

West Africa

Countries with recognized endemic transmission include several areas of the region where the rodent reservoir is common.

Reservoir

The major reservoir is:

Mastomys natalensis

commonly called the:

Multimammate rat

These rodents can carry and shed the virus without necessarily becoming severely ill.

Transmission

Human infection commonly occurs after exposure to:

Rodent urine or feces

Transmission may occur through:

• Contaminated food

• Contaminated household surfaces

• Inhalation of aerosolized contaminated particles

• Direct contact with rodent excreta

Person-to-Person Transmission

Lassa virus can also spread between humans through:

Direct contact with infected blood or body fluids

This is particularly important in:

• Household settings

• Healthcare environments

• Situations with inadequate infection-control precautions

Incubation Period

The typical incubation period is approximately:

6–21 days

Symptoms may initially be nonspecific, which can make early recognition difficult.

Lassa Fever

Clinical Manifestations

Lassa fever may range from mild illness to severe systemic disease.

Early manifestations may include:

• Fever

• Weakness

• Malaise

• Headache

• Myalgia

• Sore throat

Severe Disease

More severe infection can produce:

• Vomiting

• Diarrhea

• Abdominal or chest pain

• Facial swelling

• Hypotension

• Bleeding manifestations

• Shock

• Multiorgan dysfunction

Although classified as a viral hemorrhagic fever, major bleeding is not present in every case.

Hearing Loss

A particularly important complication of Lassa fever is:

Sensorineural hearing loss

Hearing impairment may develop during or after the acute illness and can persist after recovery.

This is one of the most characteristic complications associated with Lassa fever.

Pregnancy

Lassa fever can be especially severe during:

Pregnancy

Maternal and fetal outcomes may be poor, particularly with severe infection.

High-Yield Clinical Pattern

West Africa

• ●

Rodent exposure

• ●

Acute febrile systemic illness

• ●

Possible hemorrhagic manifestations

• ●

Sensorineural hearing loss

→ Think Lassa fever

Diagnosis

The source lists:

• Cell culture

• Serology

Modern diagnosis may also include molecular detection such as:

RT-PCR

especially during acute illness.

Serology

Serologic testing can detect:

Lassa virus-specific antibodies

and may help establish the diagnosis depending on the stage of infection.

Viral Culture

Virus isolation is possible but requires:

High-containment laboratory facilities

because of the infectious risk.

It is therefore not a routine diagnostic method in most clinical laboratories.

Treatment

The source lists:

Ribavirin

Ribavirin has historically been used for severe Lassa fever, particularly when administered early in the course of illness.

Supportive Care

Management also depends heavily on:

• Fluid and electrolyte management

• Hemodynamic support

• Oxygenation and respiratory support when necessary

• Management of bleeding

• Treatment of secondary complications

Supportive care is essential even when antiviral therapy is considered.

Prevention

The source recommends:

Strict isolation for the duration of illness

Modern infection prevention focuses on appropriate isolation and meticulous precautions against exposure to:

Blood and body fluids

Infection-Control Measures

Important measures include:

• Appropriate personal protective equipment

• Safe handling of blood and body fluids

• Safe injection practices

• Proper disposal of contaminated materials

• Appropriate laboratory precautions

• Avoiding unprotected contact with infected patients

Rodent Control

Prevention also requires limiting exposure to the reservoir.

Useful measures include:

• Keeping food in rodent-proof containers

• Maintaining clean household environments

• Reducing rodent access to homes

• Avoiding consumption of food contaminated with rodent excreta

• Safe handling of rodents

Lassa Virus vs. Ebola Virus

Lassa virus

→ Arenavirus

→ Rodent reservoir

→ West Africa

→ Ribavirin historically used

→ Hearing loss is a characteristic complication

Ebola virus

→ Filovirus

→ Primarily spread through infected body fluids during outbreaks

→ Severe hemorrhagic/systemic illness

→ Specific monoclonal antibody therapies are available for some Ebola virus disease

High-Yield Reservoir Pattern

Mastomys natalensis

• ●

Rodent urine/feces exposure

• ●

West Africa

→ Lassa virus

Exam Essentials

Virus: Lassa virus

Family: Arenaviridae

Genus: Mammarenavirus

Genome: Two segmented single-stranded RNA segments

Envelope: Present

Nucleocapsid symmetry: Helical

Geography: West Africa

Reservoir: Mastomys natalensis

Transmission: Rodent excreta; infected human blood/body fluids

Disease: Lassa fever

Incubation: Approximately 6–21 days

Major complication: Sensorineural hearing loss

Diagnosis: Serology, RT-PCR; culture in specialized laboratories

Treatment in source: Ribavirin

Supportive care: Essential

Prevention: Rodent control and strict blood/body-fluid infection precautions

Key clinical pearl: Think of Lassa fever in a patient from or exposed in West Africa who develops an acute febrile illness after rodent exposure, particularly when sensorineural hearing loss occurs. The classic reservoir is the multimammate rat, Mastomys natalensis.

Infectious Disease and Microbiology – Lactobacillus Species

Overview

Lactobacillus species are Gram-positive, microaerophilic bacilli that normally colonize several areas of the human body, particularly the vagina, oral cavity, and gastrointestinal tract. They are also commonly present in fermented foods and some probiotic preparations.

Although Lactobacillus organisms are usually beneficial commensals with low pathogenic potential, they can occasionally cause serious opportunistic infections such as bacteremia and endocarditis, particularly when host defenses or normal anatomic barriers are disrupted.

Important Species

The source lists:

• Lactobacillus acidophilus

• Lactobacillus casei

• Lactobacillus plantarum

• Lactobacillus rhamnosus

• Lactobacillus salivarius

• Other Lactobacillus species

Taxonomy within this group has undergone substantial revision, so several organisms historically classified as Lactobacillus have subsequently been reassigned to other genera.

Microbiologic Characteristics

Lactobacillus species are generally:

• Gram-positive bacilli

• Non-spore-forming

• Microaerophilic or aerotolerant

• Catalase-negative

• Lactic acid-producing organisms

Their ability to produce lactic acid is especially important in maintaining the normal vaginal environment.

Normal Human Flora

Lactobacillus species commonly colonize the:

Vagina

Oral cavity

Gastrointestinal tract

Therefore, recovery of Lactobacillus from a nonsterile specimen does not necessarily indicate infection.

Vaginal Microbiology

Protective Role of Lactobacilli

In the healthy reproductive-age vagina, lactobacilli contribute to a:

Low vaginal pH

through production of lactic acid.

This acidic environment helps inhibit the proliferation of many potentially pathogenic organisms.

Thus:

Abundant vaginal lactobacilli

→ Lactic acid production

→ Low vaginal pH

→ Suppression of competing organisms

Hormonal Influence

The vaginal Lactobacillus population is influenced by the hormonal environment.

Changes in hormone levels can alter:

• Vaginal epithelial characteristics

• Glycogen availability

• Lactobacillus abundance

• Vaginal pH

• Colonization by other microorganisms

Loss or reduction of protective lactobacilli may permit overgrowth of other bacterial species.

Clinical Significance

A reduction in vaginal lactobacilli can disturb the normal vaginal microbial ecosystem.

This concept is especially important in understanding:

Bacterial vaginosis

in which normal lactobacillus-dominant flora is replaced by a polymicrobial community containing anaerobic and other organisms.

Alterations in vaginal flora may also influence susceptibility to some urinary and genital infections.

Food and Probiotic Association

Lactobacillus species are also found in various:

• Fermented foods

• Dairy products

• Probiotic preparations

Most exposure does not cause disease.

However, in unusual circumstances—particularly in highly vulnerable patients—organisms traditionally regarded as low-virulence commensals can become opportunistic pathogens.

Incubation Period

A conventional incubation period is generally not applicable because most clinically significant infections are:

Endogenous

Infection can develop when organisms belonging to the patient’s normal flora gain access to normally sterile tissues or the bloodstream.

Epidemiology

Lactobacillus species are:

Widely distributed

and commonly present as part of normal human flora.

Invasive infections are relatively uncommon compared with the frequency of colonization.

Bacteremia

Lactobacillus Bacteremia

Lactobacillus species can occasionally cause:

Bacteremia

The source particularly emphasizes bacteremia in:

Neutropenic patients

Other severely immunocompromised or critically ill patients may also be vulnerable to invasive infection.

Interpreting Positive Blood Cultures

Because Lactobacillus is normally associated with human flora, its recovery from blood requires clinical interpretation.

A positive culture should not automatically be dismissed when there are:

• Multiple positive blood cultures

• Persistent fever or sepsis

• Immunosuppression

• Neutropenia

• Evidence of endocarditis

• Another compatible invasive focus

Endocarditis

Lactobacillus species are rare but recognized causes of:

Infective endocarditis

This is one of the most important serious infections associated with the genus.

Clinical Features

Possible manifestations include:

• Persistent fever

• Bacteremia

• New or changing cardiac murmur

• Valvular vegetation

• Embolic complications

• Other manifestations of infective endocarditis

Persistent Lactobacillus bacteremia should therefore raise concern for an endovascular source.

High-Yield Endocarditis Pattern

Persistent Lactobacillus bacteremia

• ●

Compatible cardiac findings

• ●

Valvular vegetation

→ Consider Lactobacillus endocarditis

Do not automatically interpret the organism as insignificant normal flora.

Neonatal Meningitis

The source identifies:

Neonatal meningitis

as a rare invasive manifestation.

Neonates are particularly susceptible to invasive infections because of their relatively immature immune defenses.

Amnionitis

Lactobacillus species have occasionally been associated with:

Amnionitis

or infection involving the amniotic membranes and intrauterine environment.

This represents an uncommon complication because lactobacilli are normally associated with the lower female genital tract rather than invasive disease.

Mediastinitis

Another rare invasive manifestation listed in the source is:

Mediastinitis

This illustrates the ability of normally low-virulence organisms to cause severe disease when introduced into normally sterile tissues.

Diagnosis

The principal diagnostic method is:

Culture

Appropriate specimens depend on the suspected infection and may include:

• Blood cultures

• Cerebrospinal fluid

• Tissue specimens

• Amniotic specimens

• Material obtained from other normally sterile sites

Colonization vs. True Infection

An important clinical principle is distinguishing:

Normal flora/colonization

from:

True invasive infection

Isolation from the vagina, mouth, or gastrointestinal tract is usually compatible with normal colonization.

In contrast:

Repeated isolation from blood or another normally sterile site + compatible clinical disease

provides much stronger evidence of infection.

Treatment

The source lists:

Penicillin G

as the primary treatment.

Additional Treatment

The source lists:

Amoxicillin

as an additional option.

However, clinically important Lactobacillus infections are uncommon, and antimicrobial susceptibility varies among species.

Therefore, serious invasive disease should ideally be managed according to:

Species identification + antimicrobial susceptibility testing + infection site

Important Antimicrobial Consideration

Not all Lactobacillus species have identical antimicrobial susceptibility patterns.

A particularly useful clinical point is that vancomycin cannot be assumed to provide reliable activity against all lactobacilli; some species have intrinsic or substantial resistance.

Thus, treatment of serious infection should not rely solely on the assumption that every Gram-positive organism will respond to vancomycin.

Treatment Principle

For suspected invasive Lactobacillus infection:

Confirm that the isolate represents true infection

↓

Identify the species when possible

↓

Perform susceptibility testing

↓

Look for a source, especially endocarditis in persistent bacteremia

↓

Use an active antimicrobial

The source emphasizes penicillin G or amoxicillin, but definitive therapy should be individualized according to susceptibility and clinical syndrome.

Lactobacillus and Bacterial Vaginosis

A useful microbiologic contrast is:

Normal vaginal flora

→ Lactobacillus-dominant

→ Lactic acid production

→ Low vaginal pH

Bacterial vaginosis

→ Decreased protective lactobacilli

→ Increased polymicrobial anaerobic flora

→ Increased vaginal pH

→ Clue cells may be present

Thus, in the vagina, Lactobacillus is generally protective rather than pathogenic.

High-Yield Clinical Pattern

Gram-positive bacillus

• ●

Normal vaginal/oral/GI flora

• ●

Lactic acid production

• ●

Usually nonpathogenic

• ●

Rare bacteremia or endocarditis in susceptible patients

→ Think Lactobacillus

Exam Essentials

Genus: Lactobacillus

Important species in source: L. acidophilus, L. casei, L. plantarum, L. rhamnosus, L. salivarius

Morphology: Gram-positive bacillus

Oxygen relationship: Microaerophilic/aerotolerant

Major metabolic product: Lactic acid

Normal flora: Vagina, oral cavity, gastrointestinal tract

Food association: Fermented foods and some probiotics

Vaginal function: Helps maintain low vaginal pH

Incubation: Usually not applicable; infection is commonly endogenous

Major invasive infections: Endocarditis and bacteremia

Important bacteremia risk in source: Neutropenia

Other infections: Neonatal meningitis, amnionitis, mediastinitis

Diagnosis: Culture

Source treatment: Penicillin G

Additional source treatment: Amoxicillin

Important treatment principle: Susceptibility varies by species

Vancomycin: Not reliably active against all Lactobacillus species

Key clinical pearl: Lactobacillus species are normally protective Gram-positive members of the vaginal, oral, and gastrointestinal flora, but they can rarely become invasive pathogens. Persistent Lactobacillus bacteremia—especially in a vulnerable patient—should not automatically be dismissed as contamination and should prompt evaluation for a true focus such as infective endocarditis.

Important Species The source lists: • Lactobacillus acidophilus

• Lactobacillus casei

• Lactobacillus plantarum

• Lactobacillus rhamnosus

• Lactobacillus salivarius

• Other Lactobacillus species Taxonomy within this group has undergone substantial revision, so several organisms historically classified as Lactobacillus have subsequently been reassigned to other genera. 

Microbiologic Characteristics Lactobacillus species are generally: • Gram-positive bacilli

• Non-spore-forming

• Microaerophilic or aerotolerant

• Catalase-negative

• Lactic acid-producing organisms Their ability to produce lactic acid is especially important in maintaining the normal vaginal environment. 

Normal Human Flora Lactobacillus species commonly colonize the: Vagina Oral cavity Gastrointestinal tract Therefore, recovery of Lactobacillus from a nonsterile specimen does not necessarily indicate infection. 

Vaginal Microbiology Protective Role of Lactobacilli In the healthy reproductive-age vagina, lactobacilli contribute to a: Low vaginal pH through production of lactic acid. This acidic environment helps inhibit the proliferation of many potentially pathogenic organisms. Thus: Abundant vaginal lactobacilli → Lactic acid production → Low vaginal pH → Suppression of competing organisms 

Hormonal Influence The vaginal Lactobacillus population is influenced by the hormonal environment. Changes in hormone levels can alter: • Vaginal epithelial characteristics

• Glycogen availability

• Lactobacillus abundance

• Vaginal pH

• Colonization by other microorganisms Loss or reduction of protective lactobacilli may permit overgrowth of other bacterial species. 

Clinical Significance A reduction in vaginal lactobacilli can disturb the normal vaginal microbial ecosystem. This concept is especially important in understanding: Bacterial vaginosis in which normal lactobacillus-dominant flora is replaced by a polymicrobial community containing anaerobic and other organisms. Alterations in vaginal flora may also influence susceptibility to some urinary and genital infections. 

Food and Probiotic Association Lactobacillus species are also found in various: • Fermented foods

• Dairy products

• Probiotic preparations Most exposure does not cause disease. However, in unusual circumstances—particularly in highly vulnerable patients—organisms traditionally regarded as low-virulence commensals can become opportunistic pathogens. 

Incubation Period A conventional incubation period is generally not applicable because most clinically significant infections are: Endogenous Infection can develop when organisms belonging to the patient’s normal flora gain access to normally sterile tissues or the bloodstream. 

Epidemiology Lactobacillus species are: Widely distributed and commonly present as part of normal human flora. Invasive infections are relatively uncommon compared with the frequency of colonization. 

Bacteremia Lactobacillus Bacteremia Lactobacillus species can occasionally cause: Bacteremia The source particularly emphasizes bacteremia in: Neutropenic patients Other severely immunocompromised or critically ill patients may also be vulnerable to invasive infection. 

Interpreting Positive Blood Cultures Because Lactobacillus is normally associated with human flora, its recovery from blood requires clinical interpretation. A positive culture should not automatically be dismissed when there are: • Multiple positive blood cultures

• Persistent fever or sepsis

• Immunosuppression

• Neutropenia

• Evidence of endocarditis

• Another compatible invasive focus 

Endocarditis Lactobacillus species are rare but recognized causes of: Infective endocarditis This is one of the most important serious infections associated with the genus. 

Clinical Features Possible manifestations include: • Persistent fever

• Bacteremia

• New or changing cardiac murmur

• Valvular vegetation

• Embolic complications

• Other manifestations of infective endocarditis Persistent Lactobacillus bacteremia should therefore raise concern for an endovascular source. 

High-Yield Endocarditis Pattern Persistent Lactobacillus bacteremia  ●  Compatible cardiac findings  ●  Valvular vegetation → Consider Lactobacillus endocarditis Do not automatically interpret the organism as insignificant normal flora. 

Neonatal Meningitis The source identifies: Neonatal meningitis as a rare invasive manifestation. Neonates are particularly susceptible to invasive infections because of their relatively immature immune defenses. 

Amnionitis Lactobacillus species have occasionally been associated with: Amnionitis or infection involving the amniotic membranes and intrauterine environment. This represents an uncommon complication because lactobacilli are normally associated with the lower female genital tract rather than invasive disease. 

Mediastinitis Another rare invasive manifestation listed in the source is: Mediastinitis This illustrates the ability of normally low-virulence organisms to cause severe disease when introduced into normally sterile tissues. 

Diagnosis The principal diagnostic method is: Culture Appropriate specimens depend on the suspected infection and may include: • Blood cultures

• Cerebrospinal fluid

• Tissue specimens

• Amniotic specimens

• Material obtained from other normally sterile sites 

Colonization vs. True Infection An important clinical principle is distinguishing: Normal flora/colonization from: True invasive infection Isolation from the vagina, mouth, or gastrointestinal tract is usually compatible with normal colonization. In contrast: Repeated isolation from blood or another normally sterile site + compatible clinical disease provides much stronger evidence of infection. 

Treatment The source lists: Penicillin G as the primary treatment. 

Additional Treatment The source lists: Amoxicillin as an additional option. However, clinically important Lactobacillus infections are uncommon, and antimicrobial susceptibility varies among species. Therefore, serious invasive disease should ideally be managed according to: Species identification + antimicrobial susceptibility testing + infection site 

Important Antimicrobial Consideration Not all Lactobacillus species have identical antimicrobial susceptibility patterns. A particularly useful clinical point is that vancomycin cannot be assumed to provide reliable activity against all lactobacilli; some species have intrinsic or substantial resistance. Thus, treatment of serious infection should not rely solely on the assumption that every Gram-positive organism will respond to vancomycin. 

Treatment Principle For suspected invasive Lactobacillus infection: Confirm that the isolate represents true infection ↓ Identify the species when possible ↓ Perform susceptibility testing ↓ Look for a source, especially endocarditis in persistent bacteremia ↓ Use an active antimicrobial The source emphasizes penicillin G or amoxicillin, but definitive therapy should be individualized according to susceptibility and clinical syndrome. 

Lactobacillus and Bacterial Vaginosis A useful microbiologic contrast is: Normal vaginal flora → Lactobacillus-dominant

→ Lactic acid production

→ Low vaginal pH Bacterial vaginosis → Decreased protective lactobacilli

→ Increased polymicrobial anaerobic flora

→ Increased vaginal pH

→ Clue cells may be present Thus, in the vagina, Lactobacillus is generally protective rather than pathogenic. 

High-Yield Clinical Pattern Gram-positive bacillus  ●  Normal vaginal/oral/GI flora  ●  Lactic acid production  ●  Usually nonpathogenic  ●  Rare bacteremia or endocarditis in susceptible patients → Think Lactobacillus 

Exam Essentials Genus: Lactobacillus

Important species in source: L. acidophilus, L. casei, L. plantarum, L. rhamnosus, L. salivarius

Morphology: Gram-positive bacillus

Oxygen relationship: Microaerophilic/aerotolerant

Major metabolic product: Lactic acid

Normal flora: Vagina, oral cavity, gastrointestinal tract

Food association: Fermented foods and some probiotics

Vaginal function: Helps maintain low vaginal pH

Incubation: Usually not applicable; infection is commonly endogenous

Major invasive infections: Endocarditis and bacteremia

Important bacteremia risk in source: Neutropenia

Other infections: Neonatal meningitis, amnionitis, mediastinitis

Diagnosis: Culture

Source treatment: Penicillin G

Additional source treatment: Amoxicillin

Important treatment principle: Susceptibility varies by species

Vancomycin: Not reliably active against all Lactobacillus species 

Key clinical pearl: Lactobacillus species are normally protective Gram-positive members of the vaginal, oral, and gastrointestinal flora, but they can rarely become invasive pathogens. Persistent Lactobacillus bacteremia—especially in a vulnerable patient—should not automatically be dismissed as contamination and should prompt evaluation for a true focus such as infective endocarditis.

Infectious Disease and Microbiology – Kyasanur Forest Disease Virus

Overview

Kyasanur Forest disease virus (KFDV) is an enveloped, positive-sense single-stranded RNA virus belonging to the genus Flavivirus. It causes Kyasanur Forest disease (KFD), an acute tick-borne viral hemorrhagic fever characterized by high fever, severe constitutional symptoms, and sometimes hemorrhagic manifestations.

The disease is classically associated with India, particularly forested areas of southern and southwestern India, and is sometimes called monkey fever because outbreaks in monkeys can signal viral activity in an area.

⸻

Important Correction

The source lists the major infection as:

“Hemorrhagic fever with renal syndrome.”

This is not the classic syndrome caused by Kyasanur Forest disease virus.

Hemorrhagic fever with renal syndrome (HFRS) is classically caused by hantaviruses.

KFDV instead causes:

Kyasanur Forest disease → acute febrile illness with possible hemorrhagic manifestations

Renal involvement is not the defining feature of KFD.

⸻

Classification

Virus: Kyasanur Forest disease virus

Abbreviation: KFDV

Genus: Flavivirus

Family: Flaviviridae

Disease: Kyasanur Forest disease (KFD)

It is an arthropod-borne virus (arbovirus) transmitted primarily through ticks.

⸻

Microbiologic Characteristics

KFDV is:

• Positive-sense single-stranded RNA virus

• Enveloped

• Approximately spherical in viral morphology

• A member of the Flavivirus genus

• An arbovirus

Its basic structure is similar to that of other medically important flaviviruses.

⸻

Incubation Period

The incubation period is approximately:

3–8 days

Symptoms generally begin abruptly after this incubation period.

⸻

Epidemiology

KFD was first recognized in Karnataka, India, in the Kyasanur Forest region.

The disease has subsequently been identified in additional areas of India.

The source also mentions China, Southeast Asia, and Saudi Arabia; however, the strongest classic epidemiologic association for KFD itself is:

Forested regions of India

Related tick-borne flaviviruses occur elsewhere in Asia and the Middle East.

⸻

Reservoirs and Ecology

KFDV circulates in an ecological cycle involving:

Ticks + small mammals + other vertebrate hosts

Monkeys can develop severe disease and die during outbreaks, making monkey deaths an important epidemiologic warning signal.

However, monkeys are not simply the permanent reservoir of the virus.

⸻

Vector

The principal vectors are:

Haemaphysalis ticks

Humans generally become infected after entering forest environments where infected ticks are present.

⸻

Transmission

The major route of human infection is:

Bite of an infected tick

People at increased exposure risk may include:

• Forest workers

• Farmers

• Hunters

• People collecting forest products

• Residents of affected forested regions

Routine person-to-person transmission is not considered a characteristic feature.

⸻

Kyasanur Forest Disease

Initial Febrile Phase

Disease usually begins abruptly with:

• High fever

• Severe headache

• Myalgia

• Generalized weakness

• Chills

• Gastrointestinal symptoms

Patients may become significantly ill during the initial febrile period.

⸻

Hemorrhagic Manifestations

Some patients develop:

Hemorrhagic features

which may include:

• Petechiae

• Epistaxis

• Gastrointestinal bleeding

• Other mucosal bleeding manifestations

Thrombocytopenia and other hematologic abnormalities may accompany severe disease.

⸻

Biphasic Disease

An important feature is that some patients experience a:

Biphasic illness

After apparent improvement from the initial febrile illness, fever can recur.

⸻

Neurologic Manifestations

During a second phase, some patients may develop neurologic manifestations such as:

• Severe headache

• Tremor

• Altered mental status

• Meningoencephalitic features

Thus, KFD can occasionally involve the central nervous system.

⸻

High-Yield Clinical Pattern

Forested region of India

Tick exposure

Abrupt high fever and severe myalgia

Possible hemorrhagic manifestations

→ Think Kyasanur Forest disease virus

⸻

Monkey Fever Association

A memorable epidemiologic clue is:

Monkey deaths in an endemic forest

Human tick exposure

Acute febrile hemorrhagic illness

→ Consider Kyasanur Forest disease

This explains the commonly used term:

“Monkey fever”

⸻

Diagnosis

The source lists:

• Cell culture

• Serology

• PCR

⸻

PCR

Molecular detection using:

RT-PCR

is particularly useful during the acute viremic phase.

It can detect viral RNA in appropriate clinical specimens.

⸻

Serology

Serologic testing can identify virus-specific antibodies and becomes particularly useful as the immune response develops.

Thus, diagnostic testing may depend on the stage of illness.

⸻

Viral Culture

The virus can be isolated in specialized laboratory settings, but routine clinical diagnosis generally relies more heavily on:

Molecular testing and serology

because handling live virus requires appropriate biosafety precautions.

⸻

Treatment

The source correctly emphasizes:

Symptomatic/supportive treatment

There is no established routine specific antiviral therapy that reliably eliminates KFDV infection.

⸻

Supportive Management

Management may include:

• Adequate hydration

• Hemodynamic monitoring

• Management of bleeding

• Correction of electrolyte abnormalities

• Respiratory support when necessary

• Management of neurologic complications

Patients with severe hemorrhage or hemodynamic instability require close monitoring.

⸻

Prevention

Because KFD is predominantly tick-borne, prevention focuses on reducing tick exposure.

Important measures include:

• Protective clothing in endemic forests

• Appropriate tick repellents

• Checking the body for ticks after forest exposure

• Environmental/vector-control measures where appropriate

• Public-health surveillance during outbreaks

⸻

KFD vs. Hantavirus HFRS

Kyasanur Forest disease virus

→ Flavivirus

→ Positive-sense ssRNA

→ Tick-borne

→ India

→ Acute febrile/hemorrhagic illness

→ May have a biphasic course

Hantavirus causing HFRS

→ Hantavirus

→ Negative-sense segmented ssRNA

→ Primarily rodent-associated transmission

→ Hemorrhagic fever with renal syndrome

→ Acute kidney injury is a defining manifestation

This distinction corrects the major syndrome error in the source.

⸻

Comparison With Other Flaviviruses

Kyasanur Forest disease virus

→ Tick-borne

→ Hemorrhagic febrile illness

→ India

Japanese encephalitis virus

→ Mosquito-borne

→ Encephalitis

→ Asia

Dengue virus

→ Aedes mosquito-borne

→ Fever, thrombocytopenia, vascular leakage/hemorrhagic manifestations

Yellow fever virus

→ Mosquito-borne

→ Fever, hepatitis, jaundice, hemorrhage

⸻

Exam Essentials

Virus: Kyasanur Forest disease virus (KFDV)

Genus: Flavivirus

Family: Flaviviridae

Genome: Positive-sense single-stranded RNA

Envelope: Present

Morphology: Approximately spherical

Incubation: 3–8 days

Classic geography: India

Transmission: Tick bite

Major vector: Haemaphysalis ticks

Common name: Monkey fever

Major syndrome: Acute febrile illness with possible hemorrhagic manifestations

Possible course: Biphasic

Possible complication: Neurologic disease during a second phase

Diagnosis: RT-PCR and serology

Treatment: Supportive

Prevention: Avoid/reduce tick exposure

Important correction: HFRS is classically a hantavirus syndrome, not the defining disease caused by KFDV

⸻

Key clinical pearl: Kyasanur Forest disease virus is a tick-borne flavivirus classically associated with forested regions of India. Think of KFD when forest/tick exposure is followed by abrupt high fever, severe myalgia, and possible hemorrhagic manifestations; do not confuse it with hantavirus-associated hemorrhagic fever with renal syndrome.

Infectious Disease and Microbiology – Kurthia Species

Overview

Kurthia species are aerobic Gram-positive bacilli that are widely distributed in the environment but only rarely cause human infection. Reported invasive manifestations include bacteremia and infective endocarditis.

The source particularly notes an association between infections caused by unusual aerobic Gram-positive bacilli, including Kurthia, and intravenous drug use.

Important Species

The source lists:

• Kurthia gibsonii

• Kurthia sibirica

• Kurthia zopfii

Human infections caused by these organisms are uncommon, so clinical experience and treatment data are limited.

Microbiologic Characteristics

Kurthia species are:

• Gram-positive bacilli

• Aerobic

• Generally non-spore-forming

• Environmental organisms

• Rare opportunistic human pathogens

When an unusual Gram-positive bacillus is isolated from a clinical specimen, its significance should be interpreted according to the specimen source and clinical circumstances.

Incubation Period

The incubation period is:

Unknown

A clearly defined incubation period is generally not applicable because Kurthia infections are rare and may follow environmental exposure or entry through disrupted skin or other barriers.

Epidemiology

Kurthia species have a:

Worldwide distribution

Despite their broad environmental distribution, clinically significant human infections are:

Rare

Environmental Distribution

Kurthia species have been recovered from environmental sources and may occasionally be encountered as organisms of uncertain clinical significance.

Therefore:

Isolation does not automatically equal infection.

Recovery from a normally sterile site such as blood, particularly in multiple cultures and in a patient with compatible symptoms, provides stronger evidence of true invasive disease.

Intravenous Drug Use

The source identifies:

Intravenous drug use

as a risk factor for infections caused by unusual aerobic Gram-positive bacilli, including Kurthia species.

Injection can provide organisms with direct access to the bloodstream, creating the potential for:

Bacteremia

and subsequent:

Cardiac valve infection → endocarditis

Bacteremia

Kurthia species can rarely cause:

Bacteremia

Clinical manifestations may include:

• Fever

• Chills

• Systemic inflammatory manifestations

• Persistent positive blood cultures

• Sepsis in severe cases

Persistent bacteremia should prompt investigation for a deeper focus of infection.

Endocarditis

Major Invasive Manifestation

An important reported infection is:

Infective endocarditis

This is particularly relevant when Kurthia is repeatedly recovered from blood cultures in a patient with appropriate risk factors.

Clinical Manifestations

Possible findings include:

• Persistent fever

• Cardiac murmur

• Positive blood cultures

• Valvular vegetation on echocardiography

• Embolic phenomena

• Other complications of infective endocarditis

High-Yield Endocarditis Pattern

Intravenous drug use

• ●

Persistent bacteremia

• ●

Unusual aerobic Gram-positive bacillus

• ●

Evidence of valvular infection

→ Consider Kurthia species among the rare possible causes of endocarditis.

Diagnosis

The source lists:

Culture

as the principal diagnostic method.

For suspected invasive disease, the most important specimens are typically:

Blood cultures

Species identification may require careful laboratory characterization because uncommon Gram-positive bacilli can be confused with other organisms.

Contamination vs. True Infection

Because unusual environmental Gram-positive bacilli may occasionally appear in cultures, clinicians must distinguish:

Contamination or transient colonization

from:

True invasive infection

Evidence favoring true infection includes:

• Multiple positive blood cultures

• Compatible systemic illness

• Persistent bacteremia

• Endocarditis findings

• Relevant host risk factors

Treatment

The source recommends:

Penicillin G

For endocarditis, it describes:

Penicillin G + an aminoglycoside

This represents the historical treatment approach provided in the source.

Additional Treatment

The source lists:

• Trimethoprim-sulfamethoxazole

• Chloramphenicol

• Erythromycin

Because human Kurthia infections are extremely uncommon, there are limited clinical data establishing an optimal standardized regimen.

Treatment Principle

For clinically significant Kurthia infection:

Confirm true infection

↓

Identify the organism

↓

Perform antimicrobial susceptibility testing when possible

↓

Determine whether endocarditis or another deep focus is present

↓

Select susceptibility-guided antimicrobial therapy

For endocarditis, prolonged therapy and specialist management may be necessary.

High-Yield Clinical Pattern

Rare Gram-positive bacillus

• ●

Bacteremia

• ●

Intravenous drug use or another bloodstream-access risk

• ●

Possible endocarditis

→ Think of Kurthia as a rare opportunistic pathogen.

Exam Essentials

Genus: Kurthia

Species: K. gibsonii, K. sibirica, K. zopfii

Morphology: Gram-positive bacillus

Oxygen relationship: Aerobic

Distribution: Worldwide

Frequency: Rare human pathogen

Incubation: Unknown

Important risk factor in source: Intravenous drug use

Major infections: Bacteremia and endocarditis

Diagnosis: Culture

Important diagnostic issue: Distinguish contamination from true bloodstream infection

Historical endocarditis treatment: Penicillin G + aminoglycoside

Additional agents in source: TMP-SMX, chloramphenicol, erythromycin

Modern management principle: Species identification and susceptibility-guided therapy

Key clinical pearl: Kurthia species are rare aerobic Gram-positive bacilli that can occasionally cause true bacteremia and endocarditis. When the organism is repeatedly isolated from blood—particularly in a patient with risk factors such as intravenous drug use—it should not automatically be dismissed as a contaminant.

Infectious Disease and Microbiology – Kluyvera Species

Overview

Kluyvera species are Gram-negative bacilli within the Enterobacterales that are uncommon causes of human infection. They have a worldwide distribution and may colonize humans without producing disease.

When infection occurs, it is often opportunistic or endogenous and may present as bacteremia, urinary tract infection, soft-tissue infection, or pneumonia, particularly in immunocompromised patients.

Important Species

The source lists:

• Kluyvera ascorbata

• Kluyvera cryocrescens

The source spelling “K. cryorencens” appears to be an error; the recognized species name is:

Kluyvera cryocrescens

Microbiologic Characteristics

Kluyvera species are:

• Gram-negative bacilli

• Facultatively anaerobic members of Enterobacterales

• Generally motile

• Opportunistic pathogens

• Uncommon causes of clinically significant infection

Older references may describe them simply as aerobic Gram-negative bacilli.

Incubation Period

A specific incubation period is generally not applicable because infection is usually:

Endogenous

Disease may develop when colonizing organisms enter normally sterile sites, particularly in patients with disrupted host defenses.

Epidemiology

Kluyvera species have a:

Worldwide distribution

However, clinically significant infection is:

Rare

Isolation therefore requires interpretation in the context of the patient’s symptoms, specimen source, and underlying risk factors.

Opportunistic Infection

Kluyvera behaves primarily as an opportunistic pathogen.

Infection is more likely in patients with:

• Immunosuppression

• Serious underlying illness

• Prolonged hospitalization

• Invasive devices

• Disruption of normal anatomic barriers

Nevertheless, infections can occasionally occur in otherwise healthy individuals.

Bacteremia

Kluyvera species can cause:

Bacteremia

Bloodstream infection may arise from another focus such as the:

• Urinary tract

• Soft tissues

• Respiratory tract

Severe cases may progress to systemic sepsis.

High-Yield Bacteremia Pattern

Hospitalized or immunocompromised patient

• ●

Unusual Enterobacterales isolated from blood

• ●

Possible urinary or soft-tissue source

→ Consider Kluyvera species

Urinary Tract Infection

Kluyvera species have been associated with:

Urinary tract infections

Clinical presentations may include:

• Cystitis

• Pyelonephritis

• Complicated urinary infection

• Urosepsis

Urine culture with susceptibility testing is important because antimicrobial resistance patterns may vary.

Soft-Tissue Infection

The organisms can occasionally produce:

Skin and soft-tissue infection

Potential manifestations include:

• Wound infection

• Cellulitis

• Abscess formation

Management may require both appropriate antimicrobial therapy and source control, such as drainage or debridement when indicated.

Pneumonia

The source particularly associates Kluyvera with:

Pneumonia in immunosuppressed patients

Respiratory isolation should be interpreted carefully because the clinical significance of an unusual Gram-negative organism depends on the specimen quality and evidence of true lower respiratory tract infection.

Diagnosis

The primary diagnostic method is:

Culture

Depending on the clinical syndrome, specimens may include:

• Blood

• Urine

• Respiratory specimens

• Wound material

• Abscess fluid

• Tissue specimens

Species identification and antimicrobial susceptibility testing are particularly useful because Kluyvera infections are uncommon.

Antimicrobial Resistance

Important Feature

The source emphasizes that information about antimicrobial susceptibility is limited.

Historically, Kluyvera species have demonstrated resistance to:

• Ampicillin

• First-generation cephalosporins

• Second-generation cephalosporins

Therefore, these agents should not automatically be assumed to provide reliable therapy.

Beta-Lactamase Significance

A particularly important microbiologic feature is that some Kluyvera species possess chromosomal beta-lactamases.

Kluyvera ascorbata is especially notable in antimicrobial-resistance microbiology because it has been recognized as a reservoir associated with the evolutionary origin of certain CTX-M-type extended-spectrum beta-lactamases (ESBLs).

This makes Kluyvera important not only as a rare pathogen but also in the study of beta-lactam resistance genes.

Treatment

The source states that several antimicrobial classes are usually active, including:

• Third-generation cephalosporins

• Antipseudomonal agents

• Fluoroquinolones

• Aminoglycosides

However, because susceptibility can vary, treatment should be based whenever possible on:

Culture + susceptibility testing

Additional Treatment

The source also lists:

Chloramphenicol

as an additional treatment option.

This represents an older therapeutic option and is not generally a preferred routine treatment when safer active alternatives are available.

Treatment Principle

Because Kluyvera infections are rare and resistance patterns can vary:

Identify the organism

↓

Perform antimicrobial susceptibility testing

↓

Determine the infection site and severity

↓

Select an active antimicrobial

↓

Provide source control when necessary

This approach is more useful than relying on a single standard regimen.

High-Yield Clinical Pattern

Immunocompromised or hospitalized patient

• ●

Bacteremia, UTI, soft-tissue infection, or pneumonia

• ●

Uncommon Gram-negative bacillus

• ●

Resistance to ampicillin/early-generation cephalosporins

→ Consider Kluyvera species

Resistance High-Yield Pattern

Kluyvera ascorbata

• ●

Chromosomal beta-lactamase

• ●

Evolutionary reservoir associated with CTX-M-type ESBL genes

→ Important connection between Kluyvera and antimicrobial resistance

Kluyvera vs. Klebsiella

Kluyvera

→ Rare opportunistic pathogen

→ Bacteremia, UTI, soft-tissue infection, pneumonia

→ Important beta-lactamase reservoir

→ Susceptibility-guided treatment

Klebsiella

→ Much more common pathogen

→ Pneumonia, UTI, bacteremia

→ Prominent polysaccharide capsule

→ Nonmotile

→ ESBL and carbapenemase resistance are major clinical concerns

Exam Essentials

Genus: Kluyvera

Important species: K. ascorbata, K. cryocrescens

Source correction: “K. cryorencens” → K. cryocrescens

Morphology: Gram-negative bacillus

Group: Enterobacterales

Distribution: Worldwide

Frequency: Rare human pathogen

Source of infection: Frequently endogenous/opportunistic

Major infections: Bacteremia, UTI, soft-tissue infection

Important host: Immunocompromised patients

Respiratory manifestation: Pneumonia

Diagnosis: Culture

Important resistance: Ampicillin and early-generation cephalosporins may be unreliable

Important microbiology association: K. ascorbata and CTX-M-type ESBL ancestry

Potential active agents in source: Third-generation cephalosporins, fluoroquinolones, antipseudomonal agents, aminoglycosides

Historical additional treatment: Chloramphenicol

Management principle: Susceptibility-guided antimicrobial therapy

Key clinical pearl: Kluyvera species are rare opportunistic Gram-negative bacilli that can cause bacteremia, UTI, soft-tissue infection, and pneumonia. K. ascorbata is especially notable because its chromosomal beta-lactamases are linked to the evolutionary origin of important CTX-M-type ESBL resistance determinants.

Important Species The source lists: • Kluyvera ascorbata

• Kluyvera cryocrescens The source spelling “K. cryorencens” appears to be an error; the recognized species name is: Kluyvera cryocrescens

Microbiologic Characteristics Kluyvera species are: • Gram-negative bacilli

• Facultatively anaerobic members of Enterobacterales

• Generally motile

• Opportunistic pathogens

• Uncommon causes of clinically significant infection Older references may describe them simply as aerobic Gram-negative bacilli.

Incubation Period A specific incubation period is generally not applicable because infection is usually: Endogenous Disease may develop when colonizing organisms enter normally sterile sites, particularly in patients with disrupted host defenses.

Epidemiology Kluyvera species have a: Worldwide distribution However, clinically significant infection is: Rare Isolation therefore requires interpretation in the context of the patient’s symptoms, specimen source, and underlying risk factors.

Opportunistic Infection Kluyvera behaves primarily as an opportunistic pathogen. Infection is more likely in patients with: • Immunosuppression

• Serious underlying illness

• Prolonged hospitalization

• Invasive devices

• Disruption of normal anatomic barriers Nevertheless, infections can occasionally occur in otherwise healthy individuals.

Bacteremia Kluyvera species can cause: Bacteremia Bloodstream infection may arise from another focus such as the: • Urinary tract

• Soft tissues

• Respiratory tract Severe cases may progress to systemic sepsis.

High-Yield Bacteremia Pattern Hospitalized or immunocompromised patient  ●  Unusual Enterobacterales isolated from blood  ●  Possible urinary or soft-tissue source → Consider Kluyvera species

Urinary Tract Infection Kluyvera species have been associated with: Urinary tract infections Clinical presentations may include: • Cystitis

• Pyelonephritis

• Complicated urinary infection

• Urosepsis Urine culture with susceptibility testing is important because antimicrobial resistance patterns may vary.

Soft-Tissue Infection The organisms can occasionally produce: Skin and soft-tissue infection Potential manifestations include: • Wound infection

• Cellulitis

• Abscess formation Management may require both appropriate antimicrobial therapy and source control, such as drainage or debridement when indicated.

Pneumonia The source particularly associates Kluyvera with: Pneumonia in immunosuppressed patients Respiratory isolation should be interpreted carefully because the clinical significance of an unusual Gram-negative organism depends on the specimen quality and evidence of true lower respiratory tract infection.

Diagnosis The primary diagnostic method is: Culture Depending on the clinical syndrome, specimens may include: • Blood

• Urine

• Respiratory specimens

• Wound material

• Abscess fluid

• Tissue specimens Species identification and antimicrobial susceptibility testing are particularly useful because Kluyvera infections are uncommon.

Antimicrobial Resistance Important Feature The source emphasizes that information about antimicrobial susceptibility is limited. Historically, Kluyvera species have demonstrated resistance to: • Ampicillin

• First-generation cephalosporins

• Second-generation cephalosporins Therefore, these agents should not automatically be assumed to provide reliable therapy.

Beta-Lactamase Significance A particularly important microbiologic feature is that some Kluyvera species possess chromosomal beta-lactamases. Kluyvera ascorbata is especially notable in antimicrobial-resistance microbiology because it has been recognized as a reservoir associated with the evolutionary origin of certain CTX-M-type extended-spectrum beta-lactamases (ESBLs). This makes Kluyvera important not only as a rare pathogen but also in the study of beta-lactam resistance genes.

Treatment The source states that several antimicrobial classes are usually active, including: • Third-generation cephalosporins

• Antipseudomonal agents

• Fluoroquinolones

• Aminoglycosides However, because susceptibility can vary, treatment should be based whenever possible on: Culture + susceptibility testing

Additional Treatment The source also lists: Chloramphenicol as an additional treatment option. This represents an older therapeutic option and is not generally a preferred routine treatment when safer active alternatives are available.

Treatment Principle Because Kluyvera infections are rare and resistance patterns can vary: Identify the organism ↓ Perform antimicrobial susceptibility testing ↓ Determine the infection site and severity ↓ Select an active antimicrobial ↓ Provide source control when necessary This approach is more useful than relying on a single standard regimen.

High-Yield Clinical Pattern Immunocompromised or hospitalized patient  ●  Bacteremia, UTI, soft-tissue infection, or pneumonia  ●  Uncommon Gram-negative bacillus  ●  Resistance to ampicillin/early-generation cephalosporins → Consider Kluyvera species

Resistance High-Yield Pattern Kluyvera ascorbata  ●  Chromosomal beta-lactamase  ●  Evolutionary reservoir associated with CTX-M-type ESBL genes → Important connection between Kluyvera and antimicrobial resistance

Kluyvera vs. Klebsiella Kluyvera → Rare opportunistic pathogen

→ Bacteremia, UTI, soft-tissue infection, pneumonia

→ Important beta-lactamase reservoir

→ Susceptibility-guided treatment Klebsiella → Much more common pathogen

→ Pneumonia, UTI, bacteremia

→ Prominent polysaccharide capsule

→ Nonmotile

→ ESBL and carbapenemase resistance are major clinical concerns

Exam Essentials Genus: Kluyvera

Important species: K. ascorbata, K. cryocrescens

Source correction: “K. cryorencens” → K. cryocrescens

Morphology: Gram-negative bacillus

Group: Enterobacterales

Distribution: Worldwide

Frequency: Rare human pathogen

Source of infection: Frequently endogenous/opportunistic

Major infections: Bacteremia, UTI, soft-tissue infection

Important host: Immunocompromised patients

Respiratory manifestation: Pneumonia

Diagnosis: Culture

Important resistance: Ampicillin and early-generation cephalosporins may be unreliable

Important microbiology association: K. ascorbata and CTX-M-type ESBL ancestry

Potential active agents in source: Third-generation cephalosporins, fluoroquinolones, antipseudomonal agents, aminoglycosides

Historical additional treatment: Chloramphenicol

Management principle: Susceptibility-guided antimicrobial therapy

Key clinical pearl: Kluyvera species are rare opportunistic Gram-negative bacilli that can cause bacteremia, UTI, soft-tissue infection, and pneumonia. K. ascorbata is especially notable because its chromosomal beta-lactamases are linked to the evolutionary origin of important CTX-M-type ESBL resistance determinants.

Infectious Disease and Microbiology – Klebsiella Species

Overview

Klebsiella species are Gram-negative bacilli belonging to the Enterobacterales and are important causes of both community-acquired and healthcare-associated infections. The two species emphasized in the source are Klebsiella pneumoniae and Klebsiella oxytoca.

Major clinical manifestations include pneumonia, urinary tract infection, and bacteremia. Certain Klebsiella organisms are also historically associated with rhinoscleroma and atrophic rhinitis.

⸻

Important Species

The source lists:

• Klebsiella pneumoniae

• Klebsiella oxytoca

K. pneumoniae is the most clinically important species and is a major cause of invasive and healthcare-associated infections.

⸻

Microbiologic Characteristics

Klebsiella species are:

• Gram-negative bacilli

• Facultatively anaerobic

• Members of the Enterobacterales

• Lactose fermenters

• Nonmotile

• Usually encapsulated

The prominent polysaccharide capsule contributes to the characteristic mucoid appearance of many Klebsiella colonies and is an important virulence factor.

⸻

Capsule

The capsule helps the organism resist:

Phagocytosis and host immune clearance

This contributes to its ability to cause invasive infection.

On culture, heavily encapsulated strains may produce:

Large, mucoid colonies

⸻

Incubation and Source of Infection

A specific incubation period is generally not applicable because many infections are:

Endogenous

Klebsiella species can colonize humans, particularly the:

• Gastrointestinal tract

• Oropharyngeal region

Disease may occur when colonizing organisms gain access to normally sterile sites.

⸻

Epidemiology

Klebsiella infections occur:

Worldwide

They are important causes of infection in:

• Hospitals

• Long-term care facilities

• Intensive care units

• Community settings

Healthcare-associated disease is especially important because of increasing antimicrobial resistance.

⸻

Pneumonia

Klebsiella Pneumonia

K. pneumoniae is a recognized cause of severe bacterial pneumonia.

Disease can include:

• Fever

• Productive cough

• Dyspnea

• Pulmonary consolidation

• Necrosis or abscess formation in severe cases

• Bacteremia

⸻

Classic Sputum Association

Traditional teaching associates Klebsiella pneumonia with thick:

“Currant-jelly” sputum

This results from bloody, mucoid respiratory secretions.

Although memorable for examinations, it is not present in every patient.

⸻

Radiographic Association

Classic descriptions of severe Klebsiella pneumonia include dense lobar consolidation and occasionally:

Bulging fissure sign

caused by expansion of the affected lobe.

This finding is not specific enough to establish the diagnosis but remains a classic teaching association.

⸻

High-Yield Pneumonia Pattern

Severe lobar pneumonia

Thick bloody/mucoid “currant-jelly” sputum

Encapsulated lactose-fermenting Gram-negative bacillus

→ Think Klebsiella pneumoniae

⸻

Urinary Tract Infection

Klebsiella species are important causes of:

Urinary tract infection

Clinical manifestations can include:

• Cystitis

• Pyelonephritis

• Catheter-associated UTI

• Complicated urinary infection

• Urosepsis

Healthcare exposure and urinary instrumentation increase the importance of resistant Klebsiella strains.

⸻

Bacteremia

Klebsiella can produce:

Bacteremia and sepsis

Common sources include:

• Urinary tract

• Respiratory tract

• Intra-abdominal infection

• Intravascular devices

• Other healthcare-associated infections

Bloodstream infection with highly resistant strains can be particularly difficult to treat.

⸻

Klebsiella oxytoca

K. oxytoca can cause many of the same opportunistic infections as K. pneumoniae, including:

• UTI

• Pneumonia

• Bacteremia

An additional high-yield association is:

Antibiotic-associated hemorrhagic colitis

K. oxytoca has been implicated in some cases of hemorrhagic colitis occurring after antibiotic exposure.

⸻

Rhinoscleroma

Chronic Granulomatous Infection

Rhinoscleroma is a chronic granulomatous infection involving primarily the:

Nasal cavity and upper respiratory tract

It is historically associated with:

Klebsiella rhinoscleromatis

which is closely related to and currently classified within the K. pneumoniae complex.

⸻

Clinical Manifestations

Rhinoscleroma can produce:

• Chronic nasal obstruction

• Nasal discharge

• Granulomatous masses

• Progressive fibrosis

• Deformity of affected upper-airway structures

Histopathology classically demonstrates characteristic Mikulicz cells.

⸻

Atrophic Rhinitis

Chronic atrophic rhinitis, particularly ozena, has historically been associated with:

Klebsiella ozaenae

also classified within the broader K. pneumoniae group.

It can cause chronic inflammation and atrophy of the nasal mucosa with crusting and characteristic malodor.

⸻

Diagnosis

The source lists:

Culture

as the principal diagnostic method.

Appropriate specimens depend on the site of infection and may include:

• Blood

• Urine

• Sputum or respiratory specimens

• Wound or abscess material

• Other normally sterile-site specimens

⸻

Antimicrobial Resistance

Antimicrobial resistance is one of the most important features of modern Klebsiella infections.

The source specifically emphasizes considering:

Local epidemiologic resistance patterns

including:

Extended-spectrum beta-lactamase (ESBL) production

⸻

ESBL-Producing Klebsiella

ESBL-producing organisms can hydrolyze many:

• Penicillins

• Third-generation cephalosporins

• Aztreonam

Therefore, a third-generation cephalosporin or aztreonam should not automatically be assumed to be effective when ESBL production is present.

⸻

Carbapenem Resistance

Klebsiella can also acquire carbapenemases, producing carbapenem-resistant Klebsiella.

A particularly important example is:

KPC – Klebsiella pneumoniae carbapenemase

Other carbapenemase mechanisms can also occur.

These organisms may be resistant to multiple antimicrobial classes and represent an important healthcare-associated infection-control problem.

⸻

Treatment

The source lists:

• Third-generation cephalosporin

• Aztreonam

as potential treatments.

However, antimicrobial selection must depend on:

Culture + susceptibility testing + local resistance epidemiology

because ESBL and carbapenemase production can make older empiric regimens ineffective.

⸻

Additional Treatment

The source also lists:

• Ciprofloxacin

• Imipenem

• Meropenem

• Amoxicillin-clavulanate

• Piperacillin-tazobactam

• Aminoglycosides

The appropriate agent depends on the infection site, severity, susceptibility profile, and resistance mechanism.

⸻

Treatment Principle

For serious Klebsiella infection:

Identify organism

↓

Obtain susceptibility results

↓

Determine whether ESBL/carbapenem resistance is present

↓

Select an active antimicrobial

This is more important than memorizing a single universal antibiotic regimen.

⸻

Hypervirulent Klebsiella pneumoniae

Some K. pneumoniae strains exhibit a hypervirulent phenotype capable of causing severe community-acquired invasive infection.

A particularly important syndrome is:

Pyogenic liver abscess

with possible metastatic spread to sites such as:

• Eye → endophthalmitis

• Central nervous system → meningitis or brain infection

• Other distant organs

This invasive syndrome has been particularly recognized in parts of Asia but can occur elsewhere.

⸻

High-Yield Hypervirulent Pattern

Community-acquired liver abscess

Klebsiella pneumoniae

Metastatic endophthalmitis or CNS infection

→ Consider hypervirulent K. pneumoniae

⸻

Klebsiella vs. Other Enteric Gram-Negative Bacilli

Klebsiella

→ Lactose fermenter

→ Nonmotile

→ Prominent capsule

→ Mucoid colonies

→ Pneumonia, UTI, bacteremia

Escherichia coli

→ Lactose fermenter

→ Usually motile

→ Major cause of UTI and bloodstream infection

Enterobacter

→ Lactose fermenting or variably fermenting

→ Motile

→ Important healthcare-associated pathogen

→ Clinically important inducible resistance mechanisms

⸻

High-Yield Clinical Pattern

Gram-negative rod

Lactose fermenter

Large polysaccharide capsule

Mucoid colonies

Pneumonia, UTI, or bacteremia

→ Think Klebsiella

⸻

Exam Essentials

Genus: Klebsiella

Important species: K. pneumoniae, K. oxytoca

Morphology: Gram-negative bacillus

Metabolism: Facultatively anaerobic

Lactose fermentation: Positive

Motility: Nonmotile

Major virulence factor: Polysaccharide capsule

Colony appearance: Mucoid

Distribution: Worldwide

Source: Frequently endogenous flora

Major infections: Pneumonia, UTI, bacteremia

Classic pneumonia clue: Currant-jelly sputum

K. oxytoca association: Antibiotic-associated hemorrhagic colitis

Rhinoscleroma: Historically K. rhinoscleromatis

Atrophic rhinitis/ozena: Historically K. ozaenae

Diagnosis: Culture

Important resistance mechanism: ESBL production

Major carbapenemase: KPC

Treatment principle: Susceptibility-guided antimicrobial therapy

Hypervirulent syndrome: Liver abscess with possible metastatic infection

⸻

Key clinical pearl: Klebsiella pneumoniae is an encapsulated, nonmotile, lactose-fermenting Gram-negative bacillus that commonly causes pneumonia, UTI, and bacteremia. For modern clinical practice, the most important consideration is antimicrobial resistance—especially ESBL and carbapenemase production—while the classic exam association remains severe pneumonia with thick “currant-jelly” sputum.

Infectious Disease and Microbiology – Klebsiella granulomatis

Overview

Klebsiella granulomatis, formerly known as Calymmatobacterium granulomatis, is a pleomorphic Gram-negative coccobacillus that causes granuloma inguinale (donovanosis).

Donovanosis is a chronic, progressively destructive infection involving primarily the genital and perianal regions. It occurs predominantly in tropical and subtropical areas and is uncommon in industrialized countries.

Taxonomy

Current name: Klebsiella granulomatis

Former name: Calymmatobacterium granulomatis

Older microbiology and infectious-disease literature frequently uses the former designation.

Microbiologic Characteristics

K. granulomatis is:

• A Gram-negative coccobacillus

• Pleomorphic

• Historically described as aerobic

• An intracellular organism in infected tissue

The classic microscopic finding is the:

Donovan body

Incubation Period

The incubation period is not precisely established but is generally estimated to range from approximately:

1–12 weeks

Because lesions can develop gradually, the precise exposure responsible for infection may be difficult to identify.

Epidemiology

Donovanosis is:

• Uncommon in industrialized countries

• Endemic in some tropical and subtropical regions

• Associated primarily with sexual exposure

The source also notes that occasional clusters have historically occurred in the United States.

Transmission

K. granulomatis is primarily associated with:

Sexual transmission

Risk is related to direct contact with infected lesions.

Granuloma Inguinale

Donovanosis

Infection with K. granulomatis causes:

Granuloma inguinale

also called:

Donovanosis

It is characterized by a chronic, progressive ulcerative disease involving the genital, inguinal, and perianal regions.

Characteristic Lesions

The disease classically produces:

Slowly progressive, painless genital ulcers

The lesions are typically:

• Beefy red

• Granulomatous

• Friable

• Highly vascular

• Prone to bleeding when touched

The combination of a painless, beefy-red ulcer that bleeds easily is particularly characteristic.

Progression

Without appropriate treatment, lesions may:

• Gradually enlarge

• Extend into surrounding tissue

• Become increasingly destructive

• Produce secondary bacterial infection

• Heal with fibrosis or scarring

The disease is generally chronic rather than an acute systemic infection.

Lymphadenopathy

True regional lymphadenopathy is generally uncommon.

However, subcutaneous inflammatory lesions may develop and resemble enlarged lymph nodes. These are sometimes called:

Pseudobuboes

This can help distinguish donovanosis from chancroid and lymphogranuloma venereum.

Diagnosis

The source lists:

Histologic examination

as an important diagnostic method.

Because routine culture is difficult, diagnosis is usually based on demonstration of the organism within affected tissue.

Donovan Bodies

The classic diagnostic finding is:

Donovan bodies

These are intracellular organisms seen within macrophages obtained from affected lesions.

They can be demonstrated using:

• Wright stain

• Giemsa stain

Microscopic Appearance

On microscopy:

Large mononuclear cells/macrophages

contain

Intracytoplasmic rod-shaped organisms

→ Donovan bodies

This is the classic examination clue for K. granulomatis.

Culture

The source notes that:

Culture is difficult and unreliable.

Therefore, routine bacterial culture is generally not the preferred method for establishing the diagnosis.

Treatment

The source recommends:

Doxycycline 100 mg orally every 12 hours

for:

At least 3 weeks

Treatment should continue until:

All lesions have completely healed.

Additional Treatment Options

The source lists alternatives including:

• Azithromycin

• Ciprofloxacin

• Erythromycin

• Trimethoprim-sulfamethoxazole

Regardless of the regimen selected, therapy should generally continue until complete clinical resolution of the lesions.

Treatment Duration

A key feature of donovanosis treatment is that therapy is not based solely on a fixed short course.

Instead:

Treat for at least 3 weeks

AND

Continue until all lesions have completely healed

This prolonged treatment requirement is an important examination point.

Prevention

The major preventive strategy is:

Safer-sex practices

This includes reducing exposure to active genital lesions and appropriate evaluation of sexual partners according to clinical circumstances.

Differential Diagnosis of Genital Ulcers

Donovanosis – Klebsiella granulomatis

→ Painless ulcer

→ Beefy-red and friable

→ Bleeds easily

→ Donovan bodies

Primary syphilis – Treponema pallidum

→ Usually painless, indurated chancre

→ Regional lymphadenopathy may occur

Chancroid – Haemophilus ducreyi

→ Painful, soft genital ulcer

→ Tender suppurative lymphadenopathy/buboes

Genital herpes – HSV

→ Painful grouped vesicles/ulcers

→ Often recurrent

Lymphogranuloma venereum – Chlamydia trachomatis L1–L3

→ Small initial lesion may be transient

→ Later prominent painful regional lymphadenopathy

High-Yield Clinical Pattern

Sexually active patient

• ●

Chronic painless genital ulcer

• ●

Beefy-red, friable lesion that bleeds easily

• ●

Intracellular Donovan bodies on Wright/Giemsa stain

→ Think Klebsiella granulomatis

→ Diagnosis: Donovanosis

Exam Essentials

Organism: Klebsiella granulomatis

Former name: Calymmatobacterium granulomatis

Morphology: Pleomorphic Gram-negative coccobacillus

Incubation: Approximately 1–12 weeks

Distribution: Predominantly tropical/subtropical regions

Transmission: Primarily sexual

Disease: Granuloma inguinale (donovanosis)

Classic lesion: Painless, beefy-red, friable genital ulcer

Bleeding: Lesions characteristically bleed easily

Lymphadenopathy: Usually uncommon; pseudobuboes may occur

Classic diagnostic finding: Donovan bodies

Stains: Wright or Giemsa

Culture: Difficult and unreliable

Treatment in source: Doxycycline 100 mg PO q12h

Duration: At least 3 weeks and until complete healing

Alternatives: Azithromycin, ciprofloxacin, erythromycin, or TMP-SMX

Prevention: Safer-sex practices

Key clinical pearl: Think Klebsiella granulomatis when a patient has a chronic, painless, beefy-red genital ulcer that is friable and bleeds easily. Demonstration of intracellular Donovan bodies on Wright or Giemsa staining is the classic diagnostic clue for donovanosis.

Infectious Disease and Microbiology – Kingella Species

Overview

Kingella species are Gram-negative coccobacilli that are part of the normal human oropharyngeal flora and can cause endogenous invasive infections. The most clinically important species is Kingella kingae, particularly in young children, where it is an important cause of bacteremia, septic arthritis, and osteomyelitis.

Kingella species are included in the HACEK group of fastidious Gram-negative organisms associated with infective endocarditis.

Important Species

The source lists:

• Kingella denitrificans

• Kingella kingae

Among these, K. kingae is the major human pathogen.

Microbiologic Characteristics

Kingella species are:

• Gram-negative coccobacilli

• Facultatively anaerobic

• Fastidious organisms

• Commonly associated with the upper respiratory tract

• Members of the HACEK group

Although the source lists both aerobic and facultatively anaerobic characteristics, the key practical point is that these are fastidious facultative Gram-negative organisms.

HACEK Association

The HACEK group includes:

H – Haemophilus and related organisms

A – Aggregatibacter

C – Cardiobacterium

E – Eikenella

K – Kingella

These organisms are classically associated with:

Subacute infective endocarditis

Incubation Period

The incubation period is:

Unknown

Because many infections arise from colonizing organisms already present in the upper respiratory tract, there may not be a clearly defined exposure-to-disease interval.

Epidemiology

Kingella infection is usually:

Endogenous

The organism may colonize the:

• Oropharynx

• Upper respiratory tract

Disease can occur when the organism enters the bloodstream and disseminates to distant sites.

Age Association

Kingella kingae is especially important in:

Infants and young children

It is a major cause of invasive osteoarticular infection in children, particularly in the preschool age group.

Bacteremia

Bacteremia occurs particularly in:

Children

It may be transient or associated with focal infection such as:

• Septic arthritis

• Osteomyelitis

• Endocarditis

Septic Arthritis

K. kingae is a well-recognized cause of:

Septic arthritis in young children

Commonly affected joints include large joints such as:

• Hip

• Knee

• Ankle

The illness may be less toxic or dramatic than septic arthritis caused by more aggressive organisms such as Staphylococcus aureus.

Osteomyelitis

Kingella kingae can also cause:

Osteomyelitis

This is particularly important in young children with:

• Limping

• Refusal to walk

• Localized bone pain

• Mild fever

• Elevated inflammatory markers

Clinical findings may be relatively subtle.

Osteoarticular Disease Pattern

A high-yield pattern is:

Young child

• ●

Mild fever

• ●

Limp or refusal to bear weight

• ●

Septic arthritis or osteomyelitis

→ Think Kingella kingae

Endocarditis

As a member of the HACEK group, Kingella can cause:

Infective endocarditis

This may have a:

• Subacute course

• Prolonged fever

• New or changing murmur

• Persistent bacteremia

• Embolic complications

HACEK Endocarditis Pattern

Fastidious Gram-negative organism

• ●

Subacute endocarditis

• ●

Oropharyngeal flora

→ Consider a HACEK organism, including Kingella

Normal Flora and Pathogenesis

Because Kingella can be part of normal human flora, infection often begins with:

Oropharyngeal colonization

followed by:

Mucosal invasion

then:

Bacteremia

and finally:

Seeding of bone, joint, or cardiac tissue

Suttonella indologenes

The source notes that:

Suttonella indologenes

was previously called:

Kingella indologenes

This organism has been associated with:

Eye infections

It is taxonomically distinct from the clinically important K. kingae.

Diagnosis

The source lists:

Culture

as the primary diagnostic method.

Culture Considerations

Kingella species can be fastidious, so routine culture may occasionally be difficult.

For suspected osteoarticular infection, specimens may include:

• Blood cultures

• Synovial fluid

• Bone aspirate

• Tissue specimens

Molecular Diagnosis

In modern practice, PCR-based testing can improve detection of K. kingae, particularly in children with suspected bone or joint infection when standard cultures are negative.

This is especially useful because the organism may be present in low numbers and may grow slowly.

Treatment

The source recommends:

Penicillin G combined with an aminoglycoside

This reflects an older treatment approach, especially for endocarditis.

Modern Treatment Considerations

For many Kingella infections, treatment is generally based on a:

Beta-lactam antibiotic

depending on susceptibility and infection site.

Potential agents may include:

• Penicillin derivatives

• Ampicillin

• Cephalosporins

For severe invasive disease or endocarditis, therapy should be guided by susceptibility testing and specialist recommendations.

Endocarditis Therapy

Historically, HACEK endocarditis was often treated with:

Penicillin + aminoglycoside

However, modern practice more commonly favors effective third-generation cephalosporins or other active beta-lactams, depending on susceptibility and local guidance.

High-Yield Clinical Pattern – Child

Preschool child

• ●

Limp/refusal to walk

• ●

Septic arthritis or osteomyelitis

• ●

Relatively mild systemic illness

→ Think Kingella kingae

High-Yield Clinical Pattern – Endocarditis

Subacute endocarditis

• ●

Fastidious Gram-negative coccobacillus

• ●

HACEK organism

→ Consider Kingella

Kingella vs. Other HACEK Organisms

Kingella

→ Young children

→ Septic arthritis

→ Osteomyelitis

→ Endocarditis

Aggregatibacter

→ Endocarditis

→ Oral flora

Cardiobacterium

→ Endocarditis

Eikenella

→ Human bite wounds

→ Oral flora

→ Endocarditis

Exam Essentials

Genus: Kingella

Important species: K. kingae

Morphology: Gram-negative coccobacillus

Metabolism: Facultatively anaerobic

Normal habitat: Oropharyngeal flora

HACEK member: Yes

Incubation: Unknown

Transmission/pathogenesis: Usually endogenous

Major pediatric disease: Septic arthritis and osteomyelitis

Bacteremia: More common in children

Endocarditis: Important HACEK manifestation

Diagnosis: Culture; PCR may improve detection

Historical treatment: Penicillin G + aminoglycoside

Modern principle: Susceptibility-guided beta-lactam therapy

Former Kingella species: Kingella indologenes → Suttonella indologenes

Key clinical pearl: Kingella kingae is a HACEK Gram-negative coccobacillus and an important cause of septic arthritis, osteomyelitis, and bacteremia in young children. A preschool child with a limp or refusal to bear weight and relatively mild systemic symptoms should prompt consideration of K. kingae.

Infectious Disease and Microbiology – Cystoisospora belli

Overview

Cystoisospora belli, historically called Isospora belli, is an intestinal coccidian protozoan parasite that causes cystoisosporiasis (formerly isosporiasis).

Infection occurs worldwide and typically produces watery diarrhea and malabsorption. Disease can become particularly severe, prolonged, and recurrent in immunocompromised patients, especially those with advanced HIV infection/AIDS.

Important Taxonomic Change

The organism was historically known as:

Isospora belli

The currently accepted name is:

Cystoisospora belli

Therefore:

Isospora belli → Cystoisospora belli

and:

Isosporiasis → Cystoisosporiasis

Older infectious-disease and parasitology references frequently use the former terminology.

Microbiologic Characteristics

C. belli is:

• A protozoan parasite

• An intestinal coccidian parasite

• An obligate intracellular organism during portions of its life cycle

• Associated primarily with infection of the small intestinal epithelium

It is related clinically to other intestinal coccidian parasites such as Cyclospora cayetanensis and Cryptosporidium species.

Incubation Period

The source lists the incubation period as:

Unknown

Clinical disease generally develops after ingestion of environmentally matured infective oocysts.

Epidemiology

C. belli has a:

Worldwide distribution

Infection is particularly important in tropical and subtropical regions and in populations with impaired cellular immunity.

Transmission

Transmission occurs primarily through the:

Fecal-oral route

Humans acquire infection by ingesting sporulated oocysts from contaminated:

• Food

• Water

• Environmental sources

Important Transmission Feature

Oocysts passed in human feces are generally not immediately infectious.

They must undergo:

Sporulation in the environment

before becoming infective.

Therefore, immediate direct person-to-person transmission is less efficient than with organisms whose infective stages are passed directly in stool.

Cystoisosporiasis

Clinical Infection

Infection with C. belli causes:

Cystoisosporiasis

The major clinical manifestations described in the source are:

• Diarrhea

• Malabsorption

• Eosinophilia

Diarrhea

The characteristic gastrointestinal manifestation is:

Watery, nonbloody diarrhea

In immunocompetent individuals, infection may eventually resolve spontaneously.

In immunocompromised patients, diarrhea may become:

• Persistent

• Profuse

• Chronic

• Relapsing

Malabsorption

Because the parasite infects the small intestinal epithelium, prolonged disease can cause:

Malabsorption

This may result in:

• Weight loss

• Nutritional deficiencies

• Weakness

• Dehydration

Severe chronic infection can therefore produce substantial nutritional consequences.

Eosinophilia

An especially useful clinical clue is:

Peripheral eosinophilia

Eosinophilia is relatively characteristic of Cystoisospora compared with several other intestinal protozoal infections.

Thus:

Chronic watery diarrhea + eosinophilia

should raise suspicion for Cystoisospora belli in the appropriate epidemiologic setting.

Infection in HIV/AIDS

Important Association

C. belli is an important opportunistic intestinal pathogen in patients with:

Advanced HIV infection/AIDS

Impaired cellular immunity can result in severe and persistent disease.

Clinical Pattern in AIDS

Patients may develop:

• Profuse watery diarrhea

• Chronic diarrhea

• Abdominal discomfort

• Severe weight loss

• Malabsorption

• Dehydration

• Electrolyte abnormalities

• Recurrent infection after treatment

Effective HIV treatment and immune restoration are important components of long-term management.

Diagnosis

Diagnosis is primarily based on:

Parasitologic examination of concentrated stool specimens

The organism’s characteristic:

Oocysts

can be detected microscopically.

Because oocyst shedding can be intermittent, examination of multiple stool specimens may improve diagnostic sensitivity.

Kinyoun Stain

The source specifically lists:

Kinyoun stain

This is a modified acid-fast staining technique useful for detecting the parasite’s oocysts.

The oocysts can demonstrate variable acid-fast staining.

Oocyst Morphology

Cystoisospora belli produces relatively:

Large, elongated or ellipsoidal oocysts

This morphology helps distinguish it from the smaller oocysts of other intestinal coccidia.

Modern Diagnostic Methods

Where available, molecular gastrointestinal panels or PCR-based testing may also identify Cystoisospora.

If routine stool testing is negative despite strong suspicion, repeated stool examination or specialized parasitologic testing may be necessary.

Treatment

The treatment of choice is:

Trimethoprim-sulfamethoxazole (TMP-SMX)

The source describes:

TMP 160 mg + SMX 800 mg

given as two tablets every 6 hours for 10 days, followed by the same dose every 12 hours for 3 weeks.

This reflects the regimen provided in the source; modern dosing and duration are individualized according to immune status and disease severity.

Recurrent Disease

Relapse can occur, particularly in patients with persistent immunosuppression.

Some patients with HIV may require:

Prolonged or secondary suppressive TMP-SMX therapy

until adequate immune recovery occurs.

Additional Treatment

The source lists:

Pyrimethamine 75 mg orally daily

• ●

Folinic acid 10 mg daily for 2 weeks

as an alternative approach.

Folinic acid is used with pyrimethamine to reduce bone marrow toxicity.

Other Historical Therapy

The source additionally lists:

Doxycycline + nitrofurantoin

However, this should be regarded as a historical alternative rather than a standard contemporary first-line regimen.

TMP-SMX remains the key drug to remember.

Prevention

Prevention primarily involves reducing fecal contamination of food and water through:

• Safe drinking water

• Proper sanitation

• Hand hygiene

• Appropriate food preparation

• Avoidance of fecally contaminated food and water

High-Yield Clinical Pattern

Patient with advanced HIV/AIDS

• ●

Persistent watery diarrhea

• ●

Weight loss and malabsorption

• ●

Peripheral eosinophilia

• ●

Large acid-fast oocysts in stool

→ Think Cystoisospora belli

Cystoisospora vs. Cyclospora vs. Cryptosporidium

Cystoisospora belli

→ Large, elongated oocysts

→ Modified acid-fast stain

→ Chronic watery diarrhea in AIDS

→ Eosinophilia can occur

→ TMP-SMX

Cyclospora cayetanensis

→ Spherical oocysts

→ Variably acid-fast

→ Food/water-associated prolonged watery diarrhea

→ TMP-SMX

Cryptosporidium species

→ Very small acid-fast oocysts

→ Severe chronic watery diarrhea in advanced immunosuppression

→ Not treated with TMP-SMX as the standard defining therapy

Exam Essentials

Historical name: Isospora belli

Current name: Cystoisospora belli

Organism type: Protozoan

Group: Intestinal coccidian parasite

Distribution: Worldwide

Transmission: Fecal-oral

Infective stage: Sporulated oocyst

Primary site: Small intestine

Disease: Cystoisosporiasis

Major symptom: Watery diarrhea

Other manifestations: Malabsorption, weight loss, dehydration

Important laboratory clue: Eosinophilia

Major risk group: Advanced HIV/AIDS

Diagnosis: Concentrated stool examination

Stain: Modified acid-fast/Kinyoun stain

Morphology: Large, elongated oocysts

First-line drug: TMP-SMX

Relapse: Particularly important with persistent immunosuppression

Historical alternative: Pyrimethamine + folinic acid

Key clinical pearl: Isospora belli is now called Cystoisospora belli. The classic examination pattern is advanced HIV/AIDS + chronic watery diarrhea + malabsorption + eosinophilia + large modified acid-fast oocysts in stool → treat with TMP-SMX.